AHA Coding Clinic® for HCPCS - 2011 Issue 2; FOR your INFORMATION
Clarification of the Appropriate Reporting of Outpatient Diagnostic Nuclear Medicine Procedures
The Centers for Medicare and Medicaid Services (CMS) reiterated in a recent transmittal (Transmittal 2174, CR 7342, dated March 18, 2011) that hospitals should only report HCPCS codes for radiolabeled products that they provide in the hospital outpatient department and that it would be inappropriate to report a HCPCS code for a radiolabeled product simply to bypass an edit present in the integrated outpatient code editor (I/OCE). For additional information regarding the reporting of diagnostic nuclear medicine procedures, go to http://www.cms.gov/Transmittal 2174. ...
Subscribe or sign in to view the full article.
Article Overview
This brief CMS-focused article explains an update affecting hospital outpatient diagnostic nuclear medicine reporting. It is intended for hospital outpatient coding, billing, and compliance staff who need to understand the scope of the guidance, the CMS transmittal referenced, and the general reporting context for radiolabeled products in the outpatient department.
Why This Topic Matters
It helps readers recognize that CMS guidance affects how hospital outpatient diagnostic nuclear medicine services are reported and why the referenced transmittal may be relevant to compliance workflows and claims review.
What You Will Learn
- The CMS source of the guidance discussed in the article
- The hospital outpatient context for diagnostic nuclear medicine reporting
- The general reporting issue involving radiolabeled products and outpatient claims edits
- Where the article directs readers for additional CMS information
Who Should Read This
- Hospital outpatient coders
- Billing staff
- Revenue cycle professionals
- Compliance staff
- Coding auditors
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com